>PA918075.1 JP 2019517471-A/4: A Composition and Method of Using miR-302 Precursors as Anti-Cancer Drugs for Treating Human Lung Cancers
CCACCACTTAAACGTGGATGTACTTGCTTTGAAACTAAAGAAGTAAGTGCTTCCATGTTTTGGTGATGG

